A BBB-penetrating and glioma-directing liposomal codelivery system modified with DCDX peptide was developed for targeting α7 nAChRs that were overexpressed in the glioma vascular endothelium, glioma cells, and TAM2. This evidence concerns the gene CHRNA7 and central nervous system cancer.